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     Colorectal cancer is the most common gastrointestinal cancer and the second leading cause of cancer 
deaths worldwide. The purpose of this study is to investigate the prevalence of Epstein-Barr virus in 
patients with colorectal carcinomas and polyps in comparison with healthy people. In this analytical  
case-control study, 15 patients with colorectal cancer and 20 patients with colorectal polyp were studied. 
From each patient two tissue samples were collected: one sample of the malignant tissue and one sample 
of normal colorectal tissue from an area located 15 cm away from the malignant tissue. Also the 35 
patients without malignancy as controls were sampled. Biopsy specimens were frozen under sterile 
conditions at -20. After DNA extractions, analysis of PCR to detect EBV DNA in tissue samples was 
performed with chi square test. EBV DNA were found in 60% of tumor samples (9 of 15), in 35% of 
polyp samples (7 of 20) and 40% of the non-malignant control group (14 of 35). Two cancer patients 
(13.3%) and five polyp patients (25%) had EBV DNA detected in both the tumor and the matched 
normal tissue. Statistical analysis showed no significant association between the prevalence of EBV and 
incidence colorectal cancer and polyps according to the location of the sample in comparison with the 
control group (p = 0.44). The results of the present study demonstrate the presence of EBV sequences in 
differentiated cancer tissue, polyp and non-malignant by PCR method reflects the ability of the virus to 
infect of the different colon cells.  
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INTRODUCTION 
     Colorectal cancer is the most common 
gastrointestinal cancer and the leading of cancer 
deaths in the United States of America [1]. 
Regarding the gender factor of colorectal 
cancer among women, after lung and breast 
cancer and in men after lung and prostate is 
the third rank of incidence. According to the 
world health organization, each year 875000 
new cases of the disease are recorded [2]. The 
incidence of colorectal cancer varies around the 
world, in America, Western Europe, Australia 
and Japan has the largest rate and in African 
and Asian countries has the lowest rate [3].  
The majority of colorectal cancers (regardless 
of the etiology) of adenoma polyps originate. 
Adenomatous polyps may be pedunculated or 
sessile, cancer is more common in sessile 
types. Adenomatous polyps could be tubular 
histology, villus and tubular-villus. Although 
many risk factors for development of the 
disease have been identified, such as the viral 
infection, the inherited genetic predisposition, 
the molecular mechanisms related to the 
colorectal carcinogenesis remain under 
investigation [4, 5]. Viral etiology of human 
malignancies is an intriguing subject, with the 
exception of HCV, all the known human tumor 
viruses contain DNA as their genetic material 
[6]. Epstein-Barr virus (EBV) is a member of 
the herpesvirus family with a 184-kbp long, 
double-stranded DNA genome that encodes 
more than 85 genes. As with other 
herpesviruses, EBV is an enveloped virus that 
contains a DNA core surrounded by an 
icosahedral nucleocapsid and a tegument. 
It is known that EBV infects more than 90% of 
the world’s adult population. Upon infection, 
the individual remains a life-long carrier of the 
virus [7]. Primary infection with EBV typically 
occurs within the first few years of life and is 
generally asymptomatic in most undeveloped 
countries. In more developed areas, primary 
infection can be delayed until late adolescence 
or adulthood and results in infectious 
mononucleosis in some cases. Thus, Epstein-
 




Barr virus is strongly involved in the 
pathogenesis of non-Hodgkin’s lymphomas and 
is associated also with some cases of Hodgkin’s 
diseases, Burkitt’s lymphoma, gastric and 
esophageal cancer and rarely with some benign 
gastrointestinal diseases. A potential role of 
EBV in colorectal carcinogenesis has also been 
investigated. So far, studies have provided 
contradictory results. Some authors were able to 
detect EBV DNA in colorectal 
adenocarcinomas by different laboratorial 
techniques, such as in situ hybridization and 
PCR [8-12]. In contrast, others failed to 
demonstrate the presence of EBV in tissue 
samples of colorectal cancer, even using the 
same methods of detection [13-16]. Give the 
importance of colorectal cancer as the most 
common gastrointestinal cancer and detection of 
an infectious agent in human cancers might 
have important implications in cancer treatment 
and prevention, the present study to investigate 
the prevalence of EBV in patients with 
colorectal cancer and polyps in comparison with 
healthy subjects by using PCR technique 
conducted.  
 
MATERIALS AND METHODS 
Patients 
     In this analytical case-control study, 
informed consent was received from all patients 
admitted to the Endoscopy clinic of Toos and 
Firoozgar hospital in Tehran, Iran between 
January 2013 and May 2013. In this study, 15 
patients with colorectal cancer and 20 patients 
with colorectal polyp were studied. From each 
patient two tissue samples were collected: one 
sample of the malignant tissue and one sample 
of normal colorectal tissue from an area located 
15 cm away from the malignant tissue. Also the        
35 patients without malignancy as controls were 
sampled. Sampling was performed by 
endoscopic biopsy operation. All collected 
tissue was kept frozen under -20  ْC until 
analysis. 
DNA extraction  
     The DNA was extracted using the 
KiaSpin®Tissue Kit (Kiagen CA, Iran) 
according to the manufacture’s instructions. In 
order to determine the concentration of the 
sample absorbance at a wavelength to 260 nm 
was performed by biophotometer system 
(Eppendrof, Germany). In addition, to 
determine the purity of the sample wavelength 
of 280/260 and 230/260 was also examined.  
PCR 
    In order to determine the quality of the 
extracted DNA, polymerase chain reaction 
amplification of the gene for human β-
globulin was carried out (Table 1) [17]. The 
mixture reaction PCR for a reaction volume 
of 20 µl containing 10 µl prime taq premix 
(2x) (Kiagen CA, Iran), 3 µl of sterile 
distilled water, 1 µl of forward and rivers 
primers (TAG compenhagen, Denmark), and 
5 µl of DNA template. The PCR reaction was 
carried out in accordance with the schedule of 
time and temperature. 95  ْC for 5 minutes as 
first denaturation, then 35 cycles of 95  ْC for 
50 seconds,  55  ْC for 30 seconds, 72  ْC for 40 
seconds and finally 72  ْC for 5 minutes final 
elongation was performed. In order to 
reproduce the EBV genome of samples was 
performed using specific primers (Table 1) 
[17]. The mixture reaction PCR for a reaction 
volume of 20 µl containing 10 µl prime taq 
premix (2X) (Kiagen CA, Iran), 3 µl of sterile 
distilled water, 1 µl of forward and rivers 
primers (TAG compenhagen, Denmark), and 
5 µl of DNA template. The PCR reaction was 
carried out in accordance with the schedule of 
time and temperature. 95  ْC for 5 minutes as 
first denaturation, then 35 cycles of 95  ْC for 
40 seconds, 65  ْC for 40 seconds, 72  ْC for 40 
seconds and finally 72  ْC for 5 minutes final 
elongation was performed. Then 5 µl of the 
PCR product on a 1.5% agarose gel was 
taken. 
 














EBV- R ACCTGGGAGGGCCATCGCAAGCTCC  
 
Statistical analysis 
    Statistical analysis were performed using the 
SPSS-20 (SPSS, Inc., Chicago, USA) software 
package.  
The relationship between the prevalence of 
EBV and occurrence of colorectal carcinomas 
and polyps according to the location of the 
sample and also compared with control group 
tissue samples were analyzed using the t test 
and χ
2
 test. Statistical significance was accepted 
at the 5 percent level. 
 





     In patients with colorectal cancers, EBV 
DNA were found in 60% of tumor samples (9 
of 15) as compared with 26.7% (4 of 15) of the 
normal tissue surrounding the tumor, EBV 
DNA in two patients with cancers (13.3%) was 
positive in tumor tissue and matched normal 
tissue.  
However, seven patients (46.6%) had EBV 
only in the tumor tissue, and two patients 
(13.3%) had EBV only in the normal colorectal 
tissue. In patients with colorectal polyps, EBV 
DNA was found in 35% of polyp samples (7 of 
20) as compared with 55% (11 of 20) of the 
normal tissue surrounding the polyp. EBV 
DNA in five patients with polyps (25%) was 
positive in polyp tissue and matched normal 
tissue. Two patients (10%) had EBV DNA 
only in the polyp tissue, and six patients (30%) 
had EBV only in the normal colorectal tissue. 
EBV DNA was found in 40% of patients in the 
control group of non-malignant (14 of 35). 
Statistical analysis showed no significant 
association between the prevalence of EBV 
and incidence colorectal cancer and polyps 
according to the location of the samples in 
comparison with the control group (p = 0.44). 
The results showed that the highest prevalence 
of EBV in patients with colorectal cancer in  
two age groups of 35-55 years (26.6%) and 
over 55 years (26.6%), in patients with 
colorectal polyps 35-55 years (20%),and non-
malignant control group in two age groups of 
35-55 years (14.2%) and over 55 years 
(14.2%). In terms of gender, the highest 
prevalence of EBV in patients with colorectal 
cancers in men (53.3%), in patients with 
colorectal polyps of women (25%) and in non-
malignant control group women (22.9%) have 
been observed.  
The highest prevalence rate of the virus in 
patients with cancers involvement of anatomic 
location, proximal colon (33.3%), patients had 
polyps in the proximal colon (20%) and in 
non-malignant control group were distal colon 
(40%). Statistical analysis showed no 
significant association between the prevalence 
of EBV, age groups, gender and anatomic 
location in patients with colorectal cancer and 
polyps in comparison with the control group (p 
> 0.05). 
 In all tissue samples 106 bp band that 
represents the amplification of human β-
globulin gene observed (Figure 1). Due to the 
quality and reliability of DNA extracted, PCR 
analysis with EBV specific primers was 
performed; 102 bp bands that represent the 






Figure 1. PCR analysis of β-globulin. DNA extracted from tissue samples was amplified for β-globin gene using primers 
described in methods. Amplification yielded a band of 106 bp. As positive control (+), human DNA from fresh tissue was used; 









Figure 2. PCR analysis for the detection of Epstein-Barr virus (EBV) from tissue samples. DNA extracted from tissues was 
amplified with specific primers. Amplification of fragment yielded a band of 102 bp. Positive control (+); negative control (N); 
clinical samples, lanes 1, 2 and 3; DNA molecular weight marker, M.  
 
DISCUSSION 
     In this study, we investigated carcinomas, 
polyp and non-malignant tissues for the 
presence of EBV DNA by PCR method. Results 
showed that the prevalence of viral DNA in 
specimens of colorectal carcinomas 60%, in 
colorectal polyps 35% and 40% in non-
malignant control group. Since the discovery by 
Gross of viral causation of murine leukaemia, 
the search for oncogenic viruses in human 
malignancies has exploded. Based on the 
current understanding, it has been estimated that 
some 15% of the global cancer burden can be 
linked to oncogenic tumor viruses [18]. 
Recently, the role of the Epstein-Barr virus in 
gastric cancer is well known, and expressed in 
various studies from 4% to 18% of gastric 
carcinomas [8]. Although there are many 
similar features in histology and pathogenesis 
between gastric and colorectal carcinoma, there 
have been few papers about the relationship of 
EBV with colorectal cancers. However, a great 
deal of evidences support an etiologic role of 
EBV in carcinogenesis in patients with EBV-
positive gastric carcinomas [19-21]. Moreover, 
recent studies have reported that Epstein-Barr 
virus transformed lymphoblastoid cell lines 
demonstrate alterations of methylation patterns 
when compared to peripheral blood leukocytes 
[16]. Epstein-Barr virus can be expressed 
transcripts to activate the proto-oncogene c-
myc, resulting in cell damage in various 
processes such as metabolism, cell cycle 
regulation, apoptosis, protein synthesis, 
angiogenesis and cellular connections, this wide 
range of effects caused by Epstein-Barr virus 
result in activation of clearly shown colorectal 
cancer. In a study by Boguszakova and 
colleagues biopsy specimens from 13 patients 
with adenocarcinoma of the colon and from 10 
patients with endoscopic polypectomies for 
colon adenoma were examined for the presence 
of the DNA of Epstein-Barr virus. These results 
shown failed to detect virus DNA in the biopsy 
tested [13]. Yuen et al. investigated for the 
presence of EBV in 74 cases of gastric 
adenocarcinoma and 36 cases of colorectal 
adenocarcinoma from Chinese patients by in 
situ hybridization (ISH) using an antisense 
EBER probe, but none of the colorectal 
carcinomas showed a positive signal [14].
 
Cho 
et al. reported the same result that EBV was not 
associated with colorectal tumors [15].
 
 In a 
study by Karpinsky and colleagues on the 
presence of Epstein-Barr virus DNA in 186 
sporadic colorectal cancer cases, after PCR 
analysis 19% of the tumor samples were 
positive for EBV, these results indicate no 
association between EBV and sporadic 
colorectal cancer [16].
 
However, Yanai et al. 
found that EBV was detected in 63.3% of 
Crohn’s disease cases and 60% of ulcerative 
colitis cases using in situ hybridization for 
EBV-encoded small RNA 1 (EBER-1), 
indicating that EBV infection may be related to 
IBD colonic  diseases [22]. Samaha et al. and 
Kon et al. reported that lymphoepithelioma-like 
carcinoma of rectum was probably related to EBV 
 




[10, 12]. Ruschoff and colleagues used PCR test 
to detect the EBV DNA in 20 cases of colorectal 
adenocarcinomas, EBV DNA identified in 3 
cases, these findings suggest that EBV may 
associate to colorectal tumors [9].
 
Kim et al. 
investigated for the presence of EBV in 20 cases 
of colorectal adenocarcinomas and found 2 cases 
were EBER-positive [23]. Grinstein and 
colleagues reported that the Epstein-Barr virus 
may play oncogenic role in epithelial cancers such 
as colorectal cancers, also EBV can be involved in 
carcinomas hyperplasia and dysplasia [11]. In 
another study by Liu and colleagues on detected 
Epstein-Barr virus in patients with colorectal 
cancer in China by PCR methods, EBV DNA was 
detected in 26 samples of 130 cases of colorectal 
cancers, also EBV prevalence among men   with 
cancer than women were diagnosed, they also 
introduced Epstein-Barr virus carcinogenic factors 
in colorectal cancer [8]. 
 
CONCLUSION 
    Up to 20% of cancers worldwide are thought 
to be associated with microbial pathogens, 
including bacteria and viruses. The present 
study has shown the presence of EBV 
sequences in differentiated cancer tissue, polyp 
and non-malignant by PCR method reflects the 
ability of the virus to infect of the different 
colon cells, but the carcinogenesis mechanism 
need to be clarified further. 
 
ACKNOWLEDGEMENT 
    This paper has been extracted from proposal 
No. 23796 (Performer: Miss Sahar Mehrabani-
Khasraghi). We wish to acknowledge the very 
kind help of Dr. Farzad Khalili to sample 
collection.  
We would like to express thanks of Mr Shabani 
for his kind help with this project,    and all 
patients who participated in the study. 
 
REFERENCES 
1. Burt RW. Colon cancer screening. 
Gastroenterology. 2000; 119: 837-853.  
2. Janaut V, Kollarova H. Epidemiology of 
colorectal cancer. Biomed Paper. 2001; 145:         
5-10. 
3. Parkin DM, Bary F, Ferlay J, Pisani P. Global 
cancer statistics, 2002. CA Cancer J Clin. 2005; 
55: 74-108. 
4. Allen JI. Molecular biology of colorectal 
cancer: a clinician’s review. Perspect Colon and 
Rectal Surg. 1995; 8: 181-202. 
5. Lynch HT, Lynch JF. Genetics of colonic 
cancer. Digestion. 1998; 59: 481-492. 
6. Elgui De Oliveira D. DNA viruses in human 
cancer: an integrated over view of fundamental 
mechanism of viral carcinogenesis. Cancer 
Letter. 2007; 247: 182-196. 
7. Paraskevas E, Dimitroulopoulos D. Epstein-
Barr virus infection and gastrointestinal 
disease. Annals of Gastroenterology. 2005;        
18: 386-390. 
8. Liu HX, Ding YQ, Li X, Yao KT. 
Investigation of Epstein-Barr virus in Chinese 
colorectal tumors. World J Gastroenterol. 2003; 
9: 2464-2468.  
9. Ruschoff  J, Dietmaier W, Luttges J, Seitz G,  
Bocker T, et al. Poorly differentiated colonic 
adenocarcinoma, medullary type: clinical 
Phenotypic, and molecular characteristics. Am J 
Pathol. 1997; 150: 1815-1825. 
10. Samaha S, Tawfik O, Horvat R, Bhatia P. 
Lymphoepithelioma like carcinoma of the 
colon: report of a case with histologic, 
immunohistochemical, and molecular studies 
for Epstein-Barr virus. Dis Colon Rectum. 
1998; 41: 925-928. 
11. Grinstein S, Preciado MV, Gattuso P, 
Chabay PA, Warren WH, De Matteo E, Gould 
VE. Demonstration of Epstein-Barr virus in 
carcinomas of various sites. Cancer Res. 2002; 
62: 4876-4878.  
12. Kon S, Kasai K, Tsuzuki N, Nishibe M, 
Kitagawa T, Nishibe T, Sato N. 
lymphoepithelioma-like carcinoma of rectum: 
possible relation with EBV. Pathol Res Pract. 
2001; 197: 577-582. 
13. Boguszakova L, Hirsch I, Brichacek B, 
Faltyn J, Fric P, Dvorakova H, Vonka V. 
Absence of cytomegalovirus, Epstein-Barr 
virus, and papillomavirus DNA from adenoma 
and adenocarcinoma of the colon. Acta Virol.    
1988; 32: 303-308. 
14. Yoen ST, Chung LP, Leung SY, Luk IS,  
Chan SY, Ho J. In situ detection of Epstein-Barr 
virus in gastric and colorectal adenocarcinomas. 
Am J Surg Pathol. 1994; 18: 1158-1163. 
15. Cho YJ, Chang MS, Park SH, Kim HS, Kim 
WH. In situ hybridization of Epstein-Barr virus 
in tumor cells and tumor infiltrating 
lymphocytes of the gastrointestinal tract. Hum 
Pathol. 2001; 32: 297-301. 
 




16. Karpinski P, Myszka A, Ramsey D, et al. 
Detection of viral DNA sequences in sporadic 
colorectal cancers in relation to CpG island 
methylation and methylator phenotype. Tumor 
Biol. 2011; 232: 653-659. 
17. Zaravinos A, Bizakis J, A Spandidos D. 
Prevalence of human papilloma virus and 
human herpes virus type 1-7 in human nasal 
polyposis. J Med Virol. 2009; 81: 1613-1619. 
18. Harald Zur H. Oncogenic DNA viruses. 
Oncogene. 2001; 20: 7820-7823.  
19. Tokunaga M, Land CE, Uemura Y, 
Tokudome T, Tanaka S, Sato E. Epstein-Barr  
virus in gastric carcinoma. Am J Pathol. 1993; 
143: 1250-1255.  
20. Nakamura S, Ueki T, Ueyama T, 
Tsuneyoshi M. Epstein-Barr virus in gastric 





































reference to its detection by the polymerase 
chain reaction and in situ hybridization in 99 
tumors, including a morphologic analysis. 
Cancer. 1994; 73: 2239-2249. 
21. Takano Y, Kato Y, Saegusa M, Mori S, 
Shiota M, Masuda M, Mikami T, Okayasu I. 
The role of the Epstein-Barr virus in the 
oncogenesis of EBV(+) gastric carcinomas. 
Virchows Arch. 1999; 434: 17-22. 
22. Yanai ST, Chung LP, Luk IS, Chan SY, Ho 
J. In situ detection of Epstein-Barr virus in 
gastric and colorectal adenocarcinomas. Am J 
Surg Pathol. 1994; 18: 1158-1163. 
23.  Kim YS, Paik SR, Kim HK, Yeom BW, 
Kim I, Lee D. Epstein-Barr virus and CD21 
expression in gastrointestinal tumors. Pathol 
Res Pract. 1998; 194: 705-711. 
